Megan Mahle

Ms. Megan Mahle serves as a Contract Administration Specialist within the Contract Administration Services Division of the Department of Homeland Security’s Office of Procurement Operations. In this role, she oversees the lifecycle management of professional, scientific, and technical service contracts critical to national security operations. Her responsibilities include contract execution, performance monitoring, and compliance oversight for high-integrity acquisitions in pharmaceutical preparation manufacturing and related technical domains. She ensures alignment with federal acquisition regulations and supports the agency’s mission to sustain operational readiness through reliable, mission-critical procurement solutions. Ms. Mahle collaborates with a broad network of federal contractors specializing in pharmaceutical manufacturing, chemical formulation, and laboratory services. While specific vendor relationships are not publicly disclosed, her work consistently engages qualified suppliers with cGMP certification, FDA-regulated production capabilities, and robust quality assurance systems. Her contracting approach emphasizes performance-based outcomes, rigorous technical evaluation, and long-term vendor accountability to maintain supply chain resilience for homeland security applications. Ms. Mahle’s procurement portfolio reflects a uniform preference for full and open competition, with 100% of her acquisitions conducted without set-aside designations. This approach underscores a strategic focus on technical capability and mission necessity over socioeconomic classifications, ensuring the selection of the most qualified providers regardless of business size or certification status. While small business participation is not formally prioritized in her portfolio, all awards adhere to fair and transparent procurement principles. Her primary procurement focus is on NAICS 325412—Pharmaceutical Preparation Manufacturing—encompassing the acquisition of sterile injectables, active pharmaceutical ingredients, and specialized drug formulations essential for medical countermeasures and emergency response systems. She possesses deep expertise in regulatory compliance, batch traceability, and cold-chain logistics, ensuring that procured products meet stringent federal standards for safety, efficacy, and readiness.